https://stock.noler.com/us/stock/flexion-therapeutics-inc https://stock.noler.com/us/stock/flexion-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/flexion-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/flexion-therapeutics-inc/accounts-receivable-gross-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/flexion-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/flexion-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/flexion-therapeutics-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/flexion-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/flexion-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/flexion-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/flexion-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/flexion-therapeutics-inc/aoci https://stock.noler.com/us/stock/flexion-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/flexion-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/flexion-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/flexion-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/flexion-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/flexion-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/flexion-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/flexion-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/flexion-therapeutics-inc/concentration-risk-percentage https://stock.noler.com/us/stock/flexion-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/flexion-therapeutics-inc/convertible-notes-payable https://stock.noler.com/us/stock/flexion-therapeutics-inc/cost-of-goods-sold https://stock.noler.com/us/stock/flexion-therapeutics-inc/cost-of-goods-sold-overhead https://stock.noler.com/us/stock/flexion-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/flexion-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/flexion-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/flexion-therapeutics-inc/current-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/flexion-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-issuance-costs https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/flexion-therapeutics-inc/debt-periodic-payment-terms-balloon-payment-to-be-paid https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/flexion-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/flexion-therapeutics-inc/deposit-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/depreciation https://stock.noler.com/us/stock/flexion-therapeutics-inc/dividends-declared https://stock.noler.com/us/stock/flexion-therapeutics-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/flexion-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/flexion-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/flexion-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/flexion-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/flexion-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/flexion-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/flexion-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/flexion-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/flexion-therapeutics-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/flexion-therapeutics-inc/income-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/flexion-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/flexion-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/flexion-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/flexion-therapeutics-inc/insider-transactions-stock-options/purchases https://stock.noler.com/us/stock/flexion-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/flexion-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/flexion-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/flexion-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/flexion-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/flexion-therapeutics-inc/interest-receivable https://stock.noler.com/us/stock/flexion-therapeutics-inc/interest-receivable-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/inventory https://stock.noler.com/us/stock/flexion-therapeutics-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/flexion-therapeutics-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/flexion-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/flexion-therapeutics-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/flexion-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/flexion-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/flexion-therapeutics-inc/investment-income-nonoperating https://stock.noler.com/us/stock/flexion-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/flexion-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/flexion-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/flexion-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/flexion-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/flexion-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/flexion-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/flexion-therapeutics-inc/net-income https://stock.noler.com/us/stock/flexion-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/flexion-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/oci-available-for-sale-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-income https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/flexion-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/flexion-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/other-income https://stock.noler.com/us/stock/flexion-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/flexion-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/flexion-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/flexion-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/flexion-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/flexion-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/flexion-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/flexion-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/flexion-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/flexion-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/flexion-therapeutics-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/flexion-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/flexion-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/flexion-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/flexion-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/flexion-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/flexion-therapeutics-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-issuance-of-senior-long-term-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/flexion-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/flexion-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/flexion-therapeutics-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/flexion-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/flexion-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/flexion-therapeutics-inc/public-float https://stock.noler.com/us/stock/flexion-therapeutics-inc/regulatory-liability-current https://stock.noler.com/us/stock/flexion-therapeutics-inc/repayments-of-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/flexion-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/flexion-therapeutics-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/flexion-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/flexion-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/flexion-therapeutics-inc/revenue https://stock.noler.com/us/stock/flexion-therapeutics-inc/revenue-from-collaborative-arrangement-excluding-revenue-from-contract-with-customer https://stock.noler.com/us/stock/flexion-therapeutics-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/flexion-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/flexion-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/flexion-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/flexion-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/flexion-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/flexion-therapeutics-inc/share-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/flexion-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/flexion-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/flexion-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/flexion-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/flexion-therapeutics-inc/temporary-equity-accretion-of-dividends https://stock.noler.com/us/stock/flexion-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/flexion-therapeutics-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/flexion-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/flexion-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/flexion-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/flexion-therapeutics-inc/total-assets https://stock.noler.com/us/stock/flexion-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/flexion-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/flexion-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/flexion-therapeutics-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/flexion-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/flexion-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/flexion-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted